[Federal Register Volume 61, Number 190 (Monday, September 30, 1996)]
[Notices]
[Pages 51117-51118]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-24973]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Commission on Dietary Supplement Labels; Meeting.

AGENCY: Office of Disease Prevention and Health Promotion, HHS.

ACTION: Commission on Dietary Supplement Labels: Notice of Meeting #6.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) is providing 
notice of the sixth meeting of the Commission on Dietary Supplement 
Labels.

DATES: The Commission intends to hold its meeting on October 24, 1996 
from 9 a.m. to approximately 12 noon, E.D.T., and October 25, 1996 from 
9 a.m. to 12 noon, E.D.T. at the Sheraton City Centre, 1143 New 
Hampshire Street NW., Washington, DC 20037. The meeting is open to the 
public; seating is limited.

FOR FURTHER INFORMATION CONTACT:
Kenneth D. Fisher, Ph.D., Executive Director, Commission on Dietary 
Supplement Labels, Office of Disease Prevention and Health Promotion, 
Room 738G, Hubert H. Humphrey Building, 200 Independence Ave. SW., 
Washington, DC 20201, (202) 690-7102.

SUPPLEMENTARY INFORMATION: Public Law 103-417, Section 12, authorized 
the establishment of a Commission on Dietary Supplement Labels whose 
seven members have been appointed by the President. The appointments to 
the Commission by the President and the establishment of the Commission 
by the Secretary of Health and Human Services reflect the commitment of 
the President and the Secretary to the development of a sound and 
consistent regulatory policy on labeling of dietary supplements.
    The Commission is charged with conducting a study and providing 
recommendations for regulation of label claims and statements for 
dietary supplements, including the use of supplemental literature in 
connection with their sale and, in addition, procedures for evaluation 
of label claims. The Commission is expected to evaluate how best to 
provide truthful, scientifically valid, and non-misleading information 
to consumers in order that they may make informed health care choices 
for themselves and their families. The Commission's study report may 
include recommendations on legislation, if appropriate and necessary.
    The Commission meeting agenda will include receipt and discussion 
of ad hoc Subcommittee reports and continuation of discussion of key 
issues related to labeling of dietary supplements that

[[Page 51118]]

may be included in the Commission's forthcoming report.
    The meeting is open to the public. If you require a sign language 
interpreter, please call Sandra Saunders (202) 690-7102 by 4:30 p.m. 
E.D.T. on October 16, 1996.

    Dated: September 24, 1996.
Linda D. Meyers,
Acting Deputy Director, Office of Disease Prevention and Health 
Promotion, U.S. Department of Health and Human Services.
[FR Doc. 96-24973 Filed 9-27-96; 8:45 am]
BILLING CODE 4160-17-M